GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mega Genomics Ltd (HKSE:06667) » Definitions » Gross Margin %

Mega Genomics (HKSE:06667) Gross Margin % : 43.87% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Mega Genomics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Mega Genomics's Gross Profit for the six months ended in Dec. 2023 was HK$25.2 Mil. Mega Genomics's Revenue for the six months ended in Dec. 2023 was HK$57.3 Mil. Therefore, Mega Genomics's Gross Margin % for the quarter that ended in Dec. 2023 was 43.87%.


The historical rank and industry rank for Mega Genomics's Gross Margin % or its related term are showing as below:

HKSE:06667' s Gross Margin % Range Over the Past 10 Years
Min: 56.08   Med: 63.44   Max: 71.96
Current: 58.36


During the past 5 years, the highest Gross Margin % of Mega Genomics was 71.96%. The lowest was 56.08%. And the median was 63.44%.

HKSE:06667's Gross Margin % is ranked better than
62.86% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 46.095 vs HKSE:06667: 58.36

Mega Genomics had a gross margin of 43.87% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Mega Genomics was 0.00% per year.


Mega Genomics Gross Margin % Historical Data

The historical data trend for Mega Genomics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Genomics Gross Margin % Chart

Mega Genomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
63.44 71.96 70.27 56.08 58.36

Mega Genomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial 72.86 65.99 35.97 66.04 43.87

Competitive Comparison of Mega Genomics's Gross Margin %

For the Diagnostics & Research subindustry, Mega Genomics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Genomics's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Mega Genomics's Gross Margin % falls into.



Mega Genomics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Mega Genomics's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=96.6 / 165.489
=(Revenue - Cost of Goods Sold) / Revenue
=(165.489 - 68.913) / 165.489
=58.36 %

Mega Genomics's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=25.2 / 57.337
=(Revenue - Cost of Goods Sold) / Revenue
=(57.337 - 32.183) / 57.337
=43.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Mega Genomics  (HKSE:06667) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Mega Genomics had a gross margin of 43.87% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Mega Genomics Gross Margin % Related Terms

Thank you for viewing the detailed overview of Mega Genomics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Genomics (HKSE:06667) Business Description

Traded in Other Exchanges
N/A
Address
North Garden Road, 401 Health Work, Haidian District, Beijing, CHN
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening and infectious disease diagnosis, to meet consumers' growing preventive medical needs.
Executives
Guo Meiling 2101 Beneficial owner
Lin Lin 2101 Beneficial owner
Yu Rong 2501 Other
Infinite Galaxy Health Limited 2101 Beneficial owner
Mei Nian Investment Limited 2101 Beneficial owner
Kastle Limited 2501 Other
Mega Marvelous Limited 2501 Other
Yurong Technology Limited 2101 Beneficial owner
Niu Zhencai 2201 Interest of corporation controlled by you
Mei Nian Da Jian Kang Chan Ye Kong Gu Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing He He Heng Ye Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Shi Ji Yu Neng Ke Ji You Xian Gong Si 2501 Other
Tian Jin Shi Ji Yu Neng Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner

Mega Genomics (HKSE:06667) Headlines

No Headlines